GlassScriptPhysician profile
Karen Toubi
NPI 1013322320
$1,435.42
in general payments reported to CMS, 2019-2025
20 companies · $598 in 2025
The $598 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.99 · 2020: $40.60 · 2021: $134 · 2022: $191 · 2023: $61.76 · 2024: $352 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $179.87 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $177.57 | 2022-2025 | |
| Astellas Pharma US INC | $164.13 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $116.37 | 2019-2021 | |
| Sage Therapeutics, LLC | $111.68 | 2025 | Zurzuvae |
| Novo Nordisk INC | $98.33 | 2019-2025 | Wegovy, Saxenda |
| Lilly USA, LLC | $84.59 | 2024-2025 | Zepbound, Mounjaro |
| Organon LLC | $70.04 | 2022-2025 | Nexplanon |
| Millicent US INC | $59.75 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Agile Therapeutics, INC. | $55.35 | 2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $47.93 | 2025 | |
| Becton, Dickinson and Company | $47.13 | 2022 | |
| Coopersurgical, INC. | $44.54 | 2025 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $44.15 | 2025 | Qelbree |
| Exeltis, USA INC. | $40.50 | 2024-2025 | Slynd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $23.11 | 2025 | |
| Pfizer INC. | $22.30 | 2023 | |
| Merck Sharp & Dohme LLC | $19.60 | 2021 | |
| Allergan, INC. | $15.00 | 2019 | |
| Dysis Medical, INC. | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Toubi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.